3,4-ジヒドロ-7-ヒドロキシ-2(1H)-キノリノン

7-Hydroxy-3,4-dihydrocarbostyril

HCID 2785758

基本情報

CAS
22246-18-0
標準SMILES
O=C1CCc2ccc(O)cc2N1
InChIKey
LKLSFDWYIBUGNT-UHFFFAOYSA-N
分子式
C9H9NO2
平均分子量
163.17 g/mol
単同位体質量
163.06332853

名称と識別子

優先名称
7-Hydroxy-3,4-dihydrocarbostyril
IUPAC
7-hydroxy-3,4-dihydro-1H-quinolin-2-one
現地名
3,4-ジヒドロ-7-ヒドロキシ-2(1H)-キノリノン
英語名
3,4-Dihydro-7-hydroxy-2(1H)-quinolinone
分子式
C9H9NO2
分子量
163.17

名称と別名

22246-18-03,4-Dihydro-7-hydroxy-2(1H)-quinolinone7-hydroxy-3,4-dihydroquinolin-2(1H)-one7-Hydroxy-3,4-dihydro-2(1H)-quinolinone7-Hydroxy-3,4-dihydrocarbostyril3,4-dihydroquinoline-2,7-diolVFU6XCR3Q32(1H)-QUINOLINONE, 3,4-DIHYDRO-7-HYDROXY-DTXSID703829413,4-Dihydro-7-hydroxy-2(1H)-quinolineARIPIPRAZOLE IMPURITY A [EP IMPURITY]ARIPIPRAZOLE IMPURITY A (EP IMPURITY)
名称をさらに表示
3,4-ジヒドロ-7-ヒドロキシ-2(1H)-キノリノン7-ヒドロキシ-3,4-ジヒドロキノリン-2(1H)-オン7-ヒドロキシ-3,4-ジヒドロ-2(1H)-キノリノン7-ヒドロキシ-3,4-ジヒドロカルボスチリル7-ヒドロキシ-2-オキソ-1,2,3,4-テトラヒドロキノリン3,4-ジヒドロ-7-ヒドロキシキノリン-2(1H)-オン7-HYDROXY-3,4-DIHYDRO-2(1H)-CHINOLINON7-Hydroxy-3AURORA KA-4813Aripiprazole Imp.A3,4-Dihydro-7-hydrox7-Hydroxy carbostyril
RefChem:546546DTXCID40333965606-966-57-hydroxy-3,4-dihydro-1H-quinolin-2-one3,4-Dihydro-7-hydroxycarbostyrilAripiprazole EP Impurity A3,4-Dihydro-7-hydroxyquinoline-2(1H)-oneMFCD06410891

データベース識別子

CAS
22246-18-0
PubChem CID
2785758
DTXSID
DTXSID70382941
ChEMBL
CHEMBL2430711
ChEBI
CHEBI:228791
UNII
VFU6XCR3Q3
EC Number
606-966-5
Nikkaji
J28.258H

物性

構造計算による物性

XLogP
0.7
極性表面積
49.3 Ų
水素結合供与体数
2
水素結合受容体数
2
回転可能結合数
0
重原子数
12

物理化学的性質

融点
233 · 233-237 °C
沸点
403.7 · 403.7±45.0 °C(Predicted)
比重(密度)
1.282 · 1.282±0.06 g/cm3(Predicted)
貯蔵温度
Sealed in dry,Room Temperature
溶解性
DMSO(微量)、メタノール(微量)
外見
個体

化学的性質

化学的特性Pale Yellow Powder

安全と法規制

GHS分類

GHS Classification · 6 件

This chemical does not meet GHS hazard criteria for 2% (1 of 51) of reports.

Warning

H302 (84.3%): Harmful if swallowed [Warning Acute toxicity, oral];H315 (11.8%): Causes skin irritation [Warning Skin corrosion/irritation];H317 (82.4%): May cause an allergic skin reaction [Warning Sensitization, Skin];H319 (13.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (11.8%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 51 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 1 of 51 reports by companies.;There are 6 notifications provided by 50 of 51 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (84.3%);Skin Irrit. 2 (11.8%);Skin Sens. 1 (82.4%);Eye Irrit. 2 (13.7%);STOT SE 3 (11.8%)

安全データ

wgk
3
hs_code
29334900
risk_code
22-43
化審法
新規公示化学物質(2011年3月31日以前届出)
hazard_code
Xn,Xi
safety_code
36/37

化学と産業

応用分野

用途有機合成原料。

使用3,4-Dihydro-7-hydroxyquinoline-2(1H)-one (Aripiprazole EP Impurity A) is an antitumor agent. Hydroxyindole analog inhibitor tyrosinase melanoma. This compound is also used in the preparation of aripiprazole (A771000).

サプライヤー100 社

北京京宇复瑞科技集团有限责任公司010-83694934 13671295325
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
INTATRADE GmbH+49 3493/605464 · [email protected]
Ark Pharm, Inc.847-367-3680 · [email protected]

関連反応

42 件

化合物ノート

読み込み中…